Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Synergistic antitumor effect of antiangiogenic factor genes on colon 26 produced by low-voltage electroporation

Abstract

Antiangiogenic factors are potent endothelial cell growth inhibitors that have been shown to inhibit angiogenesis in vitro and tumor growth in mice. We have demonstrated the synergistic antitumor effect of antiangiogenic genes (mouse angiostatin: pBLAST-mAngio; and mouse endostatin: p-BLAST42-mEndo XV) delivered to tumors by low-voltage electroporation in mouse colon 26 models. A synergistic antitumor effect was strongly suggested by in vivo tumor growth kinetics, as well as in survival studies with the mice. RT-PCR confirmed that the fragments of each gene were transferred by low-voltage electroporation in the tumor. Decreased microvessel density measurements in tumors also confirmed the efficacy of the synergistic antitumor effect of both genes. Significant growth inhibition was observed in mice treated with a 1:1 proportion of angiostatin and endostatin genes, and the order of the both genes transferred (first the endostatin gene, followed 1 week later by the angiostatin gene) had a profound inhibitory effect on tumor growth. These data suggest that in vivo delivery of antiangiogenic genes with low-voltage electroporation could be a possible therapeutic strategy for established solid tumors when both genes were applied in combination.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Folkman J . Tumor angiogenesis: therapeutic implications. N Eng J Med. 1971;18:1182–1187.

    Google Scholar 

  2. O'Reilly MS, Holmgren L, Shing Y, et al. A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994;79:315–328.

    Article  CAS  PubMed  Google Scholar 

  3. O'Reilly MS, Boehm T, Shing Y, et al. An endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997;88:277–285.

    Article  CAS  PubMed  Google Scholar 

  4. O'Reilly MS, Holmgren L, Chen C, Folkman J . Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med. 1996;2:689–692.

    Article  CAS  PubMed  Google Scholar 

  5. Gately S, Twardowski P, Stack MS, et al. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc Natl Acad Sci USA. 1997;94:10868–10872.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Nyuyen JT, Wu P, Clouse ME, Hlatky L, Terwilliger EF . Adeno-associated virus-mediated delivery of anti-angiogenic factors as an anti-tumor strategy. Cancer Res. 1998;58:5673–5677.

    Google Scholar 

  7. Feldman AL, Restifo NP, Alexander HR, et al. Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice. Cancer Res. 2000;60:1503–1506.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Blezinger P, Wang J, Gondo M, et al. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene. Nat Biotechnol. 1999;17:343–348.

    Article  CAS  PubMed  Google Scholar 

  9. Chen QR, Kumar D, Stass SA, Mixson AJ . Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice. Cancer Res. 1999;59:3308–3312.

    CAS  PubMed  Google Scholar 

  10. Szary J, Sazala S . Intra-tumoral administration of naked plasmid DNA encoding mouse endostatin inhibits renal carcinoma growth. Int J Cancer. 2001;91:835–839.

    Article  CAS  PubMed  Google Scholar 

  11. Ding I, Sun JZ, Fenton B, et al. Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in Mca-4 murine mammary carcinomas. Cancer Res. 2001;61:526–531.

    CAS  PubMed  Google Scholar 

  12. Muramatsu T, Nakamura A, Park HM . In vivo electroporation: a powerful and convenient means of nonviral gene transfer to tissues of living animals (review). Int J Mol Med. 1998;1:55–62.

    CAS  PubMed  Google Scholar 

  13. Heller R, Gilbert R, Jaroszeski MJ . Clinical trials of solid tumors using electrochemotherapy. In: Jaroszeski MJ, Heller R, Gilbert R, eds. Electrochemotherapy, Electrogenetherapy, and Transdermal Drug Delivery. Electrically Mediated Delivery of Molecules to Cells. Totowa, NJ: Humana Press; 2000: 137–156.

    Chapter  Google Scholar 

  14. Xie TD, Sun L, Tsong TY . Study of mechanisms of electric field-induced DNA transfection I: DNA entry by surface binding and diffusion through membrane pores. Biophys J. 1990;58:13–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Li S, Zhang X, Xia X, et al. Intramuscular electroporation delivery of INF-α gene therapy for inhibition of tumor growth located at a distant site. Gene Therapy. 2001;8:400–407.

    Article  CAS  PubMed  Google Scholar 

  16. Wells JM, Li LH, Sen A, Jahreis GP, Hui SW . Electroporation-enhanced gene delivery in mammary tumors. Gene Therapy. 2000;7:541–547.

    Article  CAS  PubMed  Google Scholar 

  17. Horiuchi A, Nikaido T, Mitsushita J, Toki T, Konishi I, Fujii S . Enhancement of anti-tumor effect of bleomycin by low-voltage in vivo electroporation: a study of human uterine leiomyosarcomas in nude mice. Int J Cancer. 2000;88:640–644.

    Article  CAS  PubMed  Google Scholar 

  18. Miyazaki S, Gunji Y, Matsubara H, et al. Possible involvement of anti-tumor immunity in the eradication of colon 26 induced by low-voltage electrochemotherapy with bleomycin. Surg Today. 2003;33:39–44.

    Article  CAS  PubMed  Google Scholar 

  19. Yamashita Y, Shimada M, Hasegawa H, et al. Electroporation-mediated Interleukin-12 gene therapy for hepatocellular carcinoma in the mice model. Cancer Res. 2001;61:1005–1012.

    CAS  PubMed  Google Scholar 

  20. Scappaticci FA, Contreras A, Smith R, et al. A novel angiostatin–endostatin fusion protein with enhanced anti-angiogenic and anti-tumor activity. Angiogenesis. 2001;4:263–268.

    Article  CAS  PubMed  Google Scholar 

  21. Somiari S, Malone JG, Drabick JJ, et al. Theory and in vivo application of electroporative gene delivery. Mol Ther. 2000;2:178–187.

    Article  CAS  PubMed  Google Scholar 

  22. Cichon T, Jamrozy L, Glogowska J, Kolka EM, Szala S . Electrotransfer of gene encoding endostatin into normal and neoplastic mouse tissues: inhibition of primary tumor growth and metastatic spread. Cancer Gene Ther. 2002;9:771–777.

    Article  CAS  PubMed  Google Scholar 

  23. Yokoyama Y, Dhanabal M, Griffioen AW, Sukhatme VP, Ramakrishnan S . Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth. Cancer Res. 2000;60:2190–2196.

    CAS  PubMed  Google Scholar 

  24. Scappaticci FA, Smith R, Pathak A, et al. Combination angiostatin and endostatin gene transfer induces synergistic anti-angiogenic activity in vitro and anti-tumor efficacy in leukemia and solid tumors in mice. Mol Ther. 2001;3:186–196.

    Article  CAS  PubMed  Google Scholar 

  25. Holmgren L, O'Reilly MS, Folkman J . Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med. 1995;1:149–153.

    Article  CAS  PubMed  Google Scholar 

  26. Lucas BR, Holmgren L, Garcia I, et al. Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood. 1998;92:4730–4741.

    CAS  PubMed  Google Scholar 

  27. Dhanabal M, Ramchandran R, Waterman MJF, et al. Endostatin induces endothelial cell apoptosis. J Biol Chem. 1999;274:11721–11726.

    Article  CAS  PubMed  Google Scholar 

  28. Griscelli F . Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc Natl Acad Sci USA. 1998;95:6367–6372.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Sasaki T, Larsson H, Tisi D, Welsh LC, Hohenester E, Timpl R . Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity. J Mol Biol. 2000;301:1179–1190.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Ms A Shioya and Ms H Kizu for excellent technical assistance and advice. This work was supported by Grants-in-Aid for 14571176 and the 21st century COE (Center of excellence) program from the Japanese Ministry of Education, Culture, sports, Science, and Technology of Japan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshio Gunji.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uesato, M., Gunji, Y., Tomonaga, T. et al. Synergistic antitumor effect of antiangiogenic factor genes on colon 26 produced by low-voltage electroporation. Cancer Gene Ther 11, 625–632 (2004). https://doi.org/10.1038/sj.cgt.7700740

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.cgt.7700740

Keywords

This article is cited by

Search

Quick links